Cargando…
CARF (CDKN2AIP) Regulates Hepatic Lipid Metabolism and Protects Against Development of Non-Alcoholic Fatty Liver Diseases
Non-alcoholic fatty liver diseases (NAFLD) is the most common form of liver diseases in the USA with 30–40% of American being affected and about 12% with nonalcoholic steatohepatitis (NASH), a leading cause of end-stage liver diseases. NAFLD has been linked with insulin resistance, type2 diabetes, o...
Autores principales: | Hasan, Kamrul M, Parveen, Meher, Pena, Alondra, Calles, Erick Galdamez, Gergis, Marvy, Espinoza-Derout, Jorge, Sinha-Hikim, Amiya, Friedman, Theodore C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089945/ http://dx.doi.org/10.1210/jendso/bvab048.577 |
Ejemplares similares
-
RF32 | PSUN44 CARF Regulates Non-Alcoholic Fatty Liver Diseases (NAFLD) by Controlling ER Stress and Lipogenesis in Hepatic Cells.
por: Friedman, Theodore, et al.
Publicado: (2022) -
SUN-550 CARF Through Its Lipid Lowering Effect May Play a Pivotal Role in the Development of Non-Alcoholic Fatty Liver Diseases
por: Hasan, Kamrul M, et al.
Publicado: (2020) -
Fatty Acid Excess Dysregulates CARF to Initiate the Development of Hepatic Steatosis
por: Hasan, Kamrul M., et al.
Publicado: (2023) -
RF19 | PSUN344 Control of Androgen Signaling and Metastasis by CARF in Prostate Cancer
por: Hasan, Kamrul, et al.
Publicado: (2022) -
SUN-067 E-cigarettes and High Fat Diet Cause Alteration in Cardiac Structure and Function
por: Hasan, Kamrul, et al.
Publicado: (2019)